E
Aibotics Inc.
AIBT
$0.018
-$0.003-14.29%
E
Sell
12/20/2024Upgraded
Mycotopia Therapies, Inc. (TPIA) was upgraded to E+ from E on 12/20/2024 due to an increase in the total return index.
Mycotopia Therapies, Inc. (TPIA) was upgraded to E+ from E on 12/20/2024 due to an increase in the total return index.
E
Sell
12/2/2024Downgrade
Mycotopia Therapies, Inc. (TPIA) was downgraded to E from E+ on 12/2/2024 due to a major decline in the solvency index and growth index. Earnings per share declined from -$0.0317 to -$0.0568, the quick ratio declined from 0.06 to 0.04, and debt to equity increased from -0.43 to -0.38.
Mycotopia Therapies, Inc. (TPIA) was downgraded to E from E+ on 12/2/2024 due to a major decline in the solvency index and growth index. Earnings per share declined from -$0.0317 to -$0.0568, the quick ratio declined from 0.06 to 0.04, and debt to equity increased from -0.43 to -0.38.
E
Sell
3/6/2023Downgrade
Mycotopia Therapies, Inc. (TPIA) was downgraded to E+ from D- on 3/6/2023 due to a decline in the volatility index.
Mycotopia Therapies, Inc. (TPIA) was downgraded to E+ from D- on 3/6/2023 due to a decline in the volatility index.
D
Sell
2/16/2023Upgraded
Mycotopia Therapies, Inc. (TPIA) was upgraded to D- from E+ on 2/16/2023 due to an increase in the volatility index.
Mycotopia Therapies, Inc. (TPIA) was upgraded to D- from E+ on 2/16/2023 due to an increase in the volatility index.
E
Sell
2/1/2023Downgrade
Mycotopia Therapies, Inc. (TPIA) was downgraded to E+ from D- on 2/1/2023 due to a decline in the volatility index and total return index.
Mycotopia Therapies, Inc. (TPIA) was downgraded to E+ from D- on 2/1/2023 due to a decline in the volatility index and total return index.
D
Sell
1/4/2023Upgraded
Mycotopia Therapies, Inc. (TPIA) was upgraded to D- from E+ on 1/4/2023 due to an increase in the volatility index.
Mycotopia Therapies, Inc. (TPIA) was upgraded to D- from E+ on 1/4/2023 due to an increase in the volatility index.
E
Sell
12/16/2022Downgrade
Mycotopia Therapies, Inc. (TPIA) was downgraded to E+ from D- on 12/16/2022 due to a decline in the volatility index.
Mycotopia Therapies, Inc. (TPIA) was downgraded to E+ from D- on 12/16/2022 due to a decline in the volatility index.
D
Sell
11/25/2022Upgraded
Mycotopia Therapies, Inc. (TPIA) was upgraded to D- from E+ on 11/25/2022 due to a noticeable increase in the growth index and valuation index.
Mycotopia Therapies, Inc. (TPIA) was upgraded to D- from E+ on 11/25/2022 due to a noticeable increase in the growth index and valuation index.
E
Sell
5/31/2022Downgrade
Mycotopia Therapies, Inc. (TPIA) was downgraded to E+ from D- on 5/31/2022 due to a decline in the growth index, total return index and volatility index. EBIT declined 348.59% from -$201.9 to -$905.7, earnings per share declined from -$0.0225 to -$0.0764, and operating cash flow declined 99.78% from -$90.1 to -$180.
Mycotopia Therapies, Inc. (TPIA) was downgraded to E+ from D- on 5/31/2022 due to a decline in the growth index, total return index and volatility index. EBIT declined 348.59% from -$201.9 to -$905.7, earnings per share declined from -$0.0225 to -$0.0764, and operating cash flow declined 99.78% from -$90.1 to -$180.
D
Sell
5/18/2022Upgraded
Mycotopia Therapies, Inc. (TPIA) was upgraded to D- from E+ on 5/18/2022 due to an increase in the valuation index.
Mycotopia Therapies, Inc. (TPIA) was upgraded to D- from E+ on 5/18/2022 due to an increase in the valuation index.
E
Sell
5/3/2022Downgrade
Mycotopia Therapies Inc. (TPIA) was downgraded to E+ from D- on 5/3/2022 due to a decline in the total return index and volatility index.
Mycotopia Therapies Inc. (TPIA) was downgraded to E+ from D- on 5/3/2022 due to a decline in the total return index and volatility index.
D
Sell
4/18/2022Upgraded
Mycotopia Therapies Inc. (TPIA) was upgraded to D- from E+ on 4/18/2022 due to an increase in the total return index, volatility index and solvency index. Debt to equity declined from 2.78 to 2.2.
Mycotopia Therapies Inc. (TPIA) was upgraded to D- from E+ on 4/18/2022 due to an increase in the total return index, volatility index and solvency index. Debt to equity declined from 2.78 to 2.2.
E
Sell
11/24/2021Downgrade
Mycotopia Therapies Inc. (TPIA) was downgraded to E+ from D- on 11/24/2021 due to a large decline in the efficiency index and valuation index. Net income declined 2,121.79% from -$107.4 to -$2.39M.
Mycotopia Therapies Inc. (TPIA) was downgraded to E+ from D- on 11/24/2021 due to a large decline in the efficiency index and valuation index. Net income declined 2,121.79% from -$107.4 to -$2.39M.
D
Sell
10/1/2021Upgraded
Mycotopia Therapies Inc. (TPIA) was upgraded to D- from E on 10/1/2021 due to an increase in the volatility index.
Mycotopia Therapies Inc. (TPIA) was upgraded to D- from E on 10/1/2021 due to an increase in the volatility index.
E
Sell
8/20/2021None
Aibotics Inc. (AIBT) was downgraded to E from U on 08/20/2021.
Aibotics Inc. (AIBT) was downgraded to E from U on 08/20/2021.
OTC PK
04/11/2025 3:29PM Eastern
Quotes delayed
